Drug
Aoc 1044
Aoc 1044: highest development phase Phase 3, developed by Avidity Biosciences, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Avidity Biosciences, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| AOC 1044 NCT07587242 | Phase 3 | Muscular Dystrophies |
Latest
No recent events.
Follow Aoc 1044 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.